Doxorubicin: all 842 studies that test it
Page 6 of 9. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on SorafenibActive, not recruitingNCT01840592Phase 2
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)CompletedNCT01839097Phase 1
- A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT01815294Phase 1
- Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian CancerCompletedNCT01809379Phase 2
- A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma PatientsStatus unknownNCT01788137Phase 3
- A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast CancerStatus unknownNCT01784120Phase 2
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Bevacizumab/Doxorubicin/Radiation for SarcomaActive, not recruitingNCT01746238Phase 1
- A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian CancerStatus unknownNCT01715168Phase 1
- Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the PlatinumCompletedNCT01705158Phase 1/2
- Anti-EGFR Immunoliposomes in Solid TumorsCompletedNCT01702129Phase 1
- PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerTerminatedNCT01697293Phase 1/2
- Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerCompletedNCT01673217Phase 1
- BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based ChemotherapyCompletedNCT01672671Phase 2
- Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast CancerCompletedNCT01669239Phase 2
- ErbB2 Positive Metastatic Breast CancerTerminatedNCT01658358Phase 1/2
- Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
- A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue SarcomaCompletedNCT01605526Phase 1
- Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple MyelomaStatus unknownNCT01541332Phase 1/2
- Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHLCompletedNCT01527422Phase 1/2
- Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk PatientsCompletedNCT01516580Phase 3
- Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab EvaluationCompletedNCT01516567Phase 2
- Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaWithdrawnNCT01492881Phase 2
- Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or LymphomasWithdrawnNCT01490047Phase 1
- Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular CarcinomaWithdrawnNCT01489410Not applicable
- EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01489371Phase 1
- Doxorubicin + BIBF 1120 in Patients for Ovarian CancerTerminatedNCT01485874Phase 1
- ACVDL Treatment for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01481194Phase 2
- International Pleuropulmonary Blastoma (PPB) Treatment and Biology RegistryActive, not recruitingNCT01464606Not applicable
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)TerminatedNCT01458548Phase 2
- Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast CancerStatus unknownNCT01451580Phase 2
- AX Versus AC as Adjuvant Treatment for Node-Negative Breast CancerStatus unknownNCT01415336Phase 2/3
- PET in Breast Cancer Receiving Neoadjuvant ChemotherapyCompletedNCT01396655Phase 2
- Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM)CompletedNCT01394354Phase 1/2
- Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)WithdrawnNCT01333423Phase 1
- Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast CancerTerminatedNCT01329627Phase 2
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01324180Phase 1
- Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast CancerStatus unknownNCT01321775Phase 2
- TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNCT01294293Phase 1
- A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
- Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II TrialStatus unknownNCT01272557Phase 2
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of ResponseTerminatedNCT01258634Phase 1
- Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALLCompletedNCT01228331Phase 2/3
- MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)TerminatedNCT01227941Phase 1
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnNCT01227408Phase 2
- A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer PatientsStatus unknownNCT01210768Phase 2
- Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast CancerCompletedNCT01206881Phase 2
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTerminatedNCT01202890Phase 1
- Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid TumoursCompletedNCT01163903Phase 1
- Molecular Triaging of Newly Diagnosed Breast CancerWithdrawnNCT01159236Not applicable
- R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCLCompletedNCT01148446Phase 3
- Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast CancerCompletedNCT01145430Phase 1
- Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat LymphomaWithdrawnNCT01139359Phase 1
- Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT01125020Not applicable
- Myocet Plus Endoxan for Older Patients With Breast CancerTerminatedNCT01120171Phase 2
- A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)TerminatedNCT01110603Phase 1
- Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerStatus unknownNCT01100372Phase 2
- Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial CancerStatus unknownNCT01100359Phase 2
- Pharmacokinetic Study of Doxorubicin in Children With CancerCompletedNCT01095926Phase 2
- Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast CancerTerminatedNCT01090128Phase 1
- Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD)CompletedNCT01088724Phase 4
- Neo Adjuvant Chemotherapy in Triple Negative Breast CancerActive, not recruitingNCT01057069Phase 2/3
- Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic CarcinomaActive, not recruitingNCT01025089Phase 2
- Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT01011010Phase 1
- Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's LymphomaStatus unknownNCT01009970Phase 2
- Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00994968Phase 2
- F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast CancerCompletedNCT00992706Phase 3
- Study in Asia of the Combination of TACE With Sorafenib in HCC PatientsStatus unknownNCT00990860Phase 2
- Study of Pegylated Human Recombinant Arginase for Liver CancerCompletedNCT00988195Phase 1
- Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast CancerCompletedNCT00976131Phase 1
- Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast CancerCompletedNCT00960336Phase 2
- Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00949182Phase 2
- Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed GlioblastomaCompletedNCT00944801Phase 1/2
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
- Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural MesotheliomaStatus unknownNCT00886028Phase 2
- Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior TherapyActive, not recruitingNCT00871013Phase 2
- UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionActive, not recruitingNCT00869232Phase 2
- Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-typeCompletedNCT00861120Phase 2
- Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung CancerCompletedNCT00856037Phase 1
- Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerCompletedNCT00846612Phase 1
- AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid TumoursTerminatedNCT00819221Phase 1
- Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's LymphomaStatus unknownNCT00816959Phase 3
- Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal TumorsCompletedNCT00815945Phase 2
- PAD. ICORG 05-01, V11CompletedNCT00814541Phase 2
- My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid LeukemiaStatus unknownNCT00801580Phase 2
- First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.CompletedNCT00801281Phase 3
- Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's DiseaseStatus unknownNCT00797472Phase 2
- Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast CancerCompletedNCT00793377Phase 3
- A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk WallStatus unknownNCT00790244Phase 2
- High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative PatientsCompletedNCT00784537Phase 2/3
- Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
- Doxil, Bevacizumab and Temsirolimus TrialCompletedNCT00761644Phase 1
- A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and EtoposideCompletedNCT00759824Phase 2
- Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian CarcinomaTerminatedNCT00758732Phase 2
- Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00744354Phase 1
- Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaStatus unknownNCT00742404Phase 2
- Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin LymphomaActive, not recruitingNCT00740805Phase 1
- A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsCompletedNCT00722293Phase 1
- Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1